HK1049006A1 - 芴衍生物 - Google Patents
芴衍生物Info
- Publication number
- HK1049006A1 HK1049006A1 HK03101305.5A HK03101305A HK1049006A1 HK 1049006 A1 HK1049006 A1 HK 1049006A1 HK 03101305 A HK03101305 A HK 03101305A HK 1049006 A1 HK1049006 A1 HK 1049006A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- fluorene derivatives
- fluorene
- derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/44—Nitrogen atoms not forming part of a nitro radical
- C07D233/48—Nitrogen atoms not forming part of a nitro radical with acyclic hydrocarbon or substituted acyclic hydrocarbon radicals, attached to said nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
- C07C279/04—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton
- C07C279/12—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton being further substituted by nitrogen atoms not being part of nitro or nitroso groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2603/00—Systems containing at least three condensed rings
- C07C2603/02—Ortho- or ortho- and peri-condensed systems
- C07C2603/04—Ortho- or ortho- and peri-condensed systems containing three rings
- C07C2603/06—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members
- C07C2603/10—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members containing five-membered rings
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Cardiology (AREA)
- Physical Education & Sports Medicine (AREA)
- Rheumatology (AREA)
- Heart & Thoracic Surgery (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Immunology (AREA)
- Hospice & Palliative Care (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19937394A DE19937394A1 (de) | 1999-08-07 | 1999-08-07 | Fluorenderivate |
PCT/EP2000/007153 WO2001010841A2 (de) | 1999-08-07 | 2000-07-26 | Fluorenderivate als integrin inhibitoren |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1049006A1 true HK1049006A1 (zh) | 2003-04-25 |
Family
ID=7917613
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK03101305.5A HK1049006A1 (zh) | 1999-08-07 | 2003-02-20 | 芴衍生物 |
Country Status (18)
Country | Link |
---|---|
EP (1) | EP1208088A2 (ja) |
JP (1) | JP2003506439A (ja) |
KR (1) | KR20020012631A (ja) |
CN (1) | CN1368962A (ja) |
AR (1) | AR025042A1 (ja) |
AU (1) | AU6828600A (ja) |
BR (1) | BR0013083A (ja) |
CA (1) | CA2380981A1 (ja) |
CZ (1) | CZ2002298A3 (ja) |
DE (1) | DE19937394A1 (ja) |
HK (1) | HK1049006A1 (ja) |
HU (1) | HUP0202464A3 (ja) |
MX (1) | MXPA02001297A (ja) |
NO (1) | NO20020592L (ja) |
PL (1) | PL353054A1 (ja) |
SK (1) | SK1402002A3 (ja) |
WO (1) | WO2001010841A2 (ja) |
ZA (1) | ZA200201873B (ja) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101102808B1 (ko) * | 2010-04-13 | 2012-01-05 | 윤태삼 | 라이저 인장 장치 |
US8574899B2 (en) | 2010-12-22 | 2013-11-05 | Vladimir B Serikov | Methods for augmentation collection of placental hematopoietic stem cells and uses thereof |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2058925A1 (en) * | 1989-06-22 | 1990-12-23 | Moshe Weitzberg | Pharmaceutical compositions and methods for treating inflammation |
IL113196A0 (en) * | 1994-03-31 | 1995-06-29 | Bristol Myers Squibb Co | Imidazole derivatives and pharmaceutical compositions containing the same |
ES2162676T3 (es) * | 1996-03-29 | 2002-01-01 | Searle & Co | Derivados de fenileno sustituidos en meta y su uso como antagonistas o inhibidores de integrina alfav,beta3. |
DE19654483A1 (de) * | 1996-06-28 | 1998-01-02 | Merck Patent Gmbh | Phenylalanin-Derivate |
CA2214931A1 (en) * | 1996-09-26 | 1998-03-26 | Henry Uhlman Bryant | Tetrahydrobenzo-a-fluorene compounds and method of use |
-
1999
- 1999-08-07 DE DE19937394A patent/DE19937394A1/de not_active Withdrawn
-
2000
- 2000-07-26 CZ CZ2002298A patent/CZ2002298A3/cs unknown
- 2000-07-26 HU HU0202464A patent/HUP0202464A3/hu unknown
- 2000-07-26 AU AU68286/00A patent/AU6828600A/en not_active Abandoned
- 2000-07-26 SK SK140-2002A patent/SK1402002A3/sk unknown
- 2000-07-26 WO PCT/EP2000/007153 patent/WO2001010841A2/de not_active Application Discontinuation
- 2000-07-26 CA CA002380981A patent/CA2380981A1/en not_active Abandoned
- 2000-07-26 BR BR0013083-4A patent/BR0013083A/pt not_active Application Discontinuation
- 2000-07-26 MX MXPA02001297A patent/MXPA02001297A/es not_active Application Discontinuation
- 2000-07-26 PL PL00353054A patent/PL353054A1/xx unknown
- 2000-07-26 JP JP2001515308A patent/JP2003506439A/ja active Pending
- 2000-07-26 KR KR1020027000660A patent/KR20020012631A/ko not_active Application Discontinuation
- 2000-07-26 CN CN00811476A patent/CN1368962A/zh active Pending
- 2000-07-26 EP EP00956284A patent/EP1208088A2/de not_active Withdrawn
- 2000-08-04 AR ARP000104035A patent/AR025042A1/es unknown
-
2002
- 2002-02-06 NO NO20020592A patent/NO20020592L/no not_active Application Discontinuation
- 2002-03-06 ZA ZA200201873A patent/ZA200201873B/xx unknown
-
2003
- 2003-02-20 HK HK03101305.5A patent/HK1049006A1/zh unknown
Also Published As
Publication number | Publication date |
---|---|
HUP0202464A3 (en) | 2003-02-28 |
AR025042A1 (es) | 2002-11-06 |
CA2380981A1 (en) | 2001-02-15 |
KR20020012631A (ko) | 2002-02-16 |
BR0013083A (pt) | 2002-04-23 |
WO2001010841A2 (de) | 2001-02-15 |
JP2003506439A (ja) | 2003-02-18 |
MXPA02001297A (es) | 2004-07-16 |
NO20020592L (no) | 2002-04-04 |
CZ2002298A3 (cs) | 2002-04-17 |
PL353054A1 (en) | 2003-10-06 |
DE19937394A1 (de) | 2001-02-08 |
SK1402002A3 (en) | 2002-06-04 |
HUP0202464A2 (hu) | 2002-12-28 |
NO20020592D0 (no) | 2002-02-06 |
AU6828600A (en) | 2001-03-05 |
WO2001010841A3 (de) | 2001-09-07 |
CN1368962A (zh) | 2002-09-11 |
ZA200201873B (en) | 2003-08-27 |
EP1208088A2 (de) | 2002-05-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EG23817A (en) | 4-Phenyl-pyridine derivatives | |
HUP0201535A2 (en) | 5-cyano-2-aminopyrimidine derivatives | |
IL148167A0 (en) | Amino-triazolopyridine derivatives | |
GC0000183A (en) | 3-Phenyl-pyridine derivatives | |
IL145739A0 (en) | 13-methyl-erythromycin derivatives | |
GC0000338A (en) | 5-Phenyl-pyrimidine derivatives | |
IL148837A0 (en) | Isoxazolecarboxamide derivatives | |
GC0000191A (en) | 4-Phenyl-pyrimidine derivatives | |
IL147636A0 (en) | 3-amino-2-benzyl-1-phenyl-propane derivatives | |
GB9925880D0 (en) | B-Carboline derivatives | |
IL150132A0 (en) | Cyclopenteneone derivatives | |
GC0000256A (en) | Ethanesulfonyl-piperidine derivatives | |
IL145949A0 (en) | 1-trifluoromethyl-4-hydroxy-7-piperidinyl-aminomethylchroman derivatives | |
PL351407A1 (en) | Thio-oxindole derivatives | |
HK1049006A1 (zh) | 芴衍生物 | |
GB9907134D0 (en) | Antimor napthylcombretastatin derivatives | |
IL146282A0 (en) | Thio-oxindole derivatives | |
SI1178984T1 (en) | 1-trifluoromethyl-4-hydroxy-7-piperidinyl-aminomethylchroman derivatives | |
HK1043987A1 (zh) | 硫-羥吲衍生物 |